nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Announcement
|
|
|
2004 |
40 |
12 |
p. 1896- 1 p. |
artikel |
2 |
An open randomised trial of second-line endocrine therapy in advanced breast cancer: comparison of the Aromatase inhibitors letrozole and anastrozole
|
Tobias, J.S |
|
2004 |
40 |
12 |
p. 1913- 1 p. |
artikel |
3 |
Calendar
|
|
|
2004 |
40 |
12 |
p. I-II nvt p. |
artikel |
4 |
Commentary on “European collaboration in trials of new agents for children with cancer” by Ablett et al.
|
Smith, Malcolm A |
|
2004 |
40 |
12 |
p. 1893-1895 3 p. |
artikel |
5 |
E-Cadherin (CDH1) and p53 rather than SMAD4 and Caspase-10 germline mutations contribute to genetic predisposition in Portuguese gastric cancer patients
|
Oliveira, Carla |
|
2004 |
40 |
12 |
p. 1897-1903 7 p. |
artikel |
6 |
Editorial board
|
|
|
2004 |
40 |
12 |
p. ii- 1 p. |
artikel |
7 |
EJC news, issue 12, 2004
|
|
|
2004 |
40 |
12 |
p. 1797-1801 5 p. |
artikel |
8 |
European collaboration in trials of new agents for children with cancer
|
Ablett, S |
|
2004 |
40 |
12 |
p. 1886-1892 7 p. |
artikel |
9 |
Evaluation of epidermal growth factor receptor tyrosine kinase inhibitors combined with chemotherapy: Is there a need for a more rational design?
|
Xu, Jian-Ming |
|
2004 |
40 |
12 |
p. 1807-1809 3 p. |
artikel |
10 |
Expression of hypoxia-inducible factor (HIF)-1α is associated with vascular endothelial growth factor expression and tumour angiogenesis in human oesophageal squamous cell carcinoma
|
Kimura, Shigeru |
|
2004 |
40 |
12 |
p. 1904-1912 9 p. |
artikel |
11 |
“Good Old” clinical markers have similar power in breast cancer prognosis as microarray gene expression profilers
|
Edén, Patrik |
|
2004 |
40 |
12 |
p. 1837-1841 5 p. |
artikel |
12 |
Impact of surgical staging in patients with macroscopic “stage I” ovarian borderline tumours: analysis of a continuous series of 101 cases
|
Camatte, Sophie |
|
2004 |
40 |
12 |
p. 1842-1849 8 p. |
artikel |
13 |
Information given to cancer patients on diagnosis, prognosis and treatment: the clinical oncologist's perspective
|
Belvedere, Ornella |
|
2004 |
40 |
12 |
p. 1850-1854 5 p. |
artikel |
14 |
Isolated hepatic perfusion for the treatment of colorectal metastases confined to the liver: recent trends and perspectives
|
Rothbarth, J |
|
2004 |
40 |
12 |
p. 1812-1824 13 p. |
artikel |
15 |
Late events occurring five years or more after successful therapy for childhood rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group
|
Sung, Lillian |
|
2004 |
40 |
12 |
p. 1878-1885 8 p. |
artikel |
16 |
LH-RH agonists offer very good protection against the adverse gynaecological effects induced by tamoxifen
|
Berlière, M |
|
2004 |
40 |
12 |
p. 1855-1861 7 p. |
artikel |
17 |
Old and new markers for breast cancer prognosis: the need for integrated research on quantitative issues
|
Biganzoli, Elia |
|
2004 |
40 |
12 |
p. 1803-1806 4 p. |
artikel |
18 |
Phase II studies of BBR3464, a novel tri-nuclear platinum complex, in patients with gastric or gastro-oesophageal adenocarcinoma
|
Jodrell, D.I |
|
2004 |
40 |
12 |
p. 1872-1877 6 p. |
artikel |
19 |
Quality of life after palliative treatment for oesophageal carcinoma – a prospective comparison between stent placement and single dose brachytherapy
|
Homs, Marjolein Y.V |
|
2004 |
40 |
12 |
p. 1862-1871 10 p. |
artikel |
20 |
Re-evaluating the role of dacarbazine in metastatic melanoma: what have we learned in 30 years?
|
Eggermont, Alexander M.M |
|
2004 |
40 |
12 |
p. 1825-1836 12 p. |
artikel |
21 |
The Hamburg statement: the partnership driving the European agenda on breast cancer
|
Jassem, J |
|
2004 |
40 |
12 |
p. 1810-1811 2 p. |
artikel |
22 |
This issue's topics
|
|
|
2004 |
40 |
12 |
p. xiii- 1 p. |
artikel |